Date published: 2025-9-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Hydrocortisone sodium phosphate (CAS 6000-74-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
Hidroaltesona
CAS Number:
6000-74-4
Purity:
≥98%
Molecular Weight:
486.40
Molecular Formula:
C21H29Na2O8P
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Hydrocortisone sodium phosphate (HSP) is a type of synthetic glucocorticoid that was developed to minimize the risk of systemic side effects typically associated with other glucocorticoids. Being water-soluble and non-esterified, it has been utilized in various fields of research, including cancer, immunology, and endocrinology, to investigate the impact of glucocorticoids on tumor growth, immune system, hormone production, and metabolism. The mechanism of action of Hydrocortisone sodium phosphate involves binding to glucocorticoid receptors, which are found in the cytoplasm of cells and are part of the nuclear hormone receptor family involved in regulating gene expression. Activation of the receptor by Hydrocortisone sodium phosphate leads to the expression of specific genes via a series of sequential events.


Hydrocortisone sodium phosphate (CAS 6000-74-4) References

  1. [Hydrocortisone Sodium Phosphate Reference Standard (Control 001) of National Institute of Health Sciences].  |  Iwata, M., et al. 2001. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 82-5. PMID: 11915292
  2. In vitro iontophoretic studies using a synthetic membrane.  |  Tu, YH. and Allen, LV. 1989. J Pharm Sci. 78: 211-3. PMID: 2724080
  3. Medical treatment of inflammatory punctual stenosis monitored by anterior segment optical coherence tomography.  |  Elalfy, HY., et al. 2020. Int J Ophthalmol. 13: 1074-1078. PMID: 32685394
  4. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application.  |  Cagini, C., et al. 2021. Int J Clin Pract. 75: e14987. PMID: 34672064
  5. Short-term results of a pulsed therapy with hydrocortisone eye drops to treat moderate to severe dry eye in primary Sjögren syndrome patients.  |  Menchini, M., et al. 2023. Graefes Arch Clin Exp Ophthalmol. 261: 1029-1036. PMID: 36192456

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Hydrocortisone sodium phosphate, 25 mg

sc-353623A
25 mg
$80.00

Hydrocortisone sodium phosphate, 100 mg

sc-353623B
100 mg
$240.00

Hydrocortisone sodium phosphate, 1 g

sc-353623
1 g
$525.00